DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
Joseph F. Fraumeni, Jr., M.D., former Director of DCEG, has been chosen to receive the William G. Anlyan, M.D., Lifetime Achievement Award from the Duke Medical Alumni Association. In announcing the award, Dr. Nancy C. Andrews, Dean of the Duke University School of Medicine, cited Dr. Fraumeni’s “numerous and far-reaching contributions …to epidemiology and environmental health during his career at the National Cancer Institute.” Read more about Dr. Fraumeni.
Xiaohong Rose Yang, Ph.D., M.P.H., was recently awarded scientific tenure by the NIH. Dr. Yang seeks to identify susceptibility genes for rare cancers that sometimes aggregate in families. To carry out this work she employs cutting-edge genomic technologies and novel statistical approaches to uncover genetic changes associated with risk for several familial cancers including melanoma and dysplastic nevi syndrome and chordoma. In her investigation of etiologic heterogeneity of breast cancer, Dr. Yang characterizes the molecular signature of tumors using tissue microarray and integrated tumor profiling analyses to identify risk factors for specific cancer subtypes. Learn more about Dr. Yang's research.
DCEG and the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences held a workshop titled “Using Immune Marker Panels to Uncover the Role of Inflammation in Cancer.” Participants discussed their work using new multiplex inflammation marker technologies and reported findings from association studies. Workshop topics included disease associations, biological interpretation of findings, assay performance, and statistical considerations. Read more about the workshop.
Since 1995, DCEG Director Stephen J. Chanock, M.D., has served as the Medical Director for Camp Fantastic, a week-long recreational camp for pediatric cancer patients. Camp Fantastic provides classes, recreation, themed adventures, campfires, and other exciting activities, and a full staff of medical caregivers make it possible for children to attend in virtually any stage of treatment. The camp is a joint venture of NCI and Special Love, Inc. Learn more about Camp Fantastic.
In June, investigators from the Occupational and Environmental Epidemiology Branch (OEEB) participated in the 24th International Epidemiology in Occupational Health (EPICOH) Conference in Chicago, Illinois. EPICOH, which is part of the International Commission on Occupational Health, provides a forum for epidemiologists, occupational hygienists, and other occupational health scientists to share information and discuss issues related to occupational exposures and their effects on human health. View a list of DCEG presenters and their topics.
An independent panel of scientists from the National Academy of Sciences (NAS) has affirmed the National Toxicology Program’s 2011 classification of formaldehyde as a “known human carcinogen” in its 12th Report of Carcinogens (RoC). Read more about the NAS panel's findings on formaldehyde carcinogenicity.
In August, DCEG scientists participated in the 29th International Papillomavirus Conference in Seattle, Washington. The meeting highlighted basic, clinical, and public health science topics ranging from molecular virology to novel cancer screening and treatment strategies to global public health.
Aimée R. Kreimer, Ph.D., presented a plenary talk on “Oral HPV natural history and its progression to oropharyngeal cancer.” View a list of other DCEG speakers and participants at the conference.
In July, Christian C. Abnet, Ph.D., M.P.H., was named Acting Chief of the Nutritional Epidemiology Branch (NEB). Dr. Abnet joined NCI as a Cancer Prevention Fellow in 1998, became a tenure-track investigator in NEB in 2005, and was awarded tenure in May 2014.
Over the past 14 years, researchers in the Clinical Genetics Branch (CGB), led by Branch Chief Sharon Savage, M.D., have carried out a study of dyskeratosis congenita (DC) at the NIH Clinical Center to better understand the disorder and to identify the genes responsible for it.
Using exome sequencing, Dr. Savage and her team have identified several genes that cause DC, including RTEL1, a gene known to be involved in telomere biology. Discovery of a rare founder mutation in this gene has led to a direct benefit for at least one DC family. Read more about this discovery.